image_alt_text
5

Yuan Luo, Ph.D.

AIMBE College of Fellows Class of 2025
For pioneering contributions to multi-modal and proactive AI frameworks advancing complex disease understanding and targeted therapeutics in biomedical informatics.

New ‘Molecular GPS’ Will Fast-Track Drug Discovery

Via Northwestern University | June 16, 2025

Largest open-access resource of its kind will help prioritize which drugs to send to clinical studies

Scientists at Northwestern University have developed the largest open-access resource of its kind to help investigators shave off months of early-stage drug development time by allowing them to better understand diseases and find potential treatments.

Called SOAR (Spatial transcriptOmics Analysis Resource), the now-live platform is a one-stop shop that helps scientists explore how genes behave differently in various parts of the body, shows them how cells might be talking to each other and enables them to find new drug possibilities… Continue reading.

...

Yuan Luo Inducted into the 2025 Class of the AIMBE College of Fellows

Via AIMBE | March 31, 2025

WASHINGTON, D.C. – The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Yuan Luo, Ph.D., Professor at Northwestern University to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”

Professor Luo was nominated, reviewed, and elected by peers and members of the College of Fellows “for pioneering contributions to multi-modal and proactive AI frameworks advancing complex disease understanding and targeted therapeutics in biomedical informatics…. Continue reading.

...